High rates of treatment stage migration for early hepatocellular carcinoma and association with adverse outcomes: An Australian multicenter study.
Kee Fong LooRichard J WoodmanDamjana BogaticVidyaleha ChandranKate MullerMohamed Asif ChinnarathaJohn BateKirsty CampbellMatthew MaddisonSumudu NarayanaHien LeDavid PryorAlan WiggPublished in: JGH open : an open access journal of gastroenterology and hepatology (2022)
Our study highlights high rates of contraindication to PA in early HCCs, resulting in TSM and poorer outcomes. The LTC rate for PA appears suboptimal despite being considered as curative therapy. Both findings support the exploration of improved treatment options for early HCCs.